Posts

Targeted radiotherapy limits side effects of breast cancer treatment

Testing for immune ‘hotspots’ can predict risk that breast cancer will return

Scientists find new method to target hard-to-treat head and neck cancers

New tests select patients who could live for nearly a year longer on targeted bowel cancer drug

ICR features in prestigious report on university-business collaboration

Dr. Alan S. Rabson, Long-Time NCI Deputy Director and Cancer Research Stalwart, Dies

The next generation – inspiring the cancer researchers of the future

Why LGBT+ representation matters in science

Ibrutinib Relieves Chronic Graft-Versus-Host Disease Symptoms

FDA Approves Rucaparib for BRCA-Positive Ovarian Cancer

The NHS at 70 – how three ICR discoveries have helped improve the lives of people with cancer